Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection

Influenza A virus (IAV) is widely disseminated across different species and can cause recurrent epidemics and severe pandemics in humans. During infection, IAV attaches to receptors that are predominantly located in cell membrane regions known as lipid rafts, which are highly enriched in cholesterol...

Full description

Bibliographic Details
Main Authors: Yu-Jyun Li, Chi-Yuan Chen, Jeng-How Yang, Ya-Fang Chiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.982264/full
_version_ 1828232314704887808
author Yu-Jyun Li
Yu-Jyun Li
Chi-Yuan Chen
Jeng-How Yang
Ya-Fang Chiu
Ya-Fang Chiu
Ya-Fang Chiu
Ya-Fang Chiu
author_facet Yu-Jyun Li
Yu-Jyun Li
Chi-Yuan Chen
Jeng-How Yang
Ya-Fang Chiu
Ya-Fang Chiu
Ya-Fang Chiu
Ya-Fang Chiu
author_sort Yu-Jyun Li
collection DOAJ
description Influenza A virus (IAV) is widely disseminated across different species and can cause recurrent epidemics and severe pandemics in humans. During infection, IAV attaches to receptors that are predominantly located in cell membrane regions known as lipid rafts, which are highly enriched in cholesterol and sphingolipids. Following IAV entry into the host cell, uncoating, transcription, and replication of the viral genome occur, after which newly synthesized viral proteins and genomes are delivered to lipid rafts for assembly prior to viral budding from the cell. Moreover, during budding, IAV acquires an envelope with embedded cholesterol from the host cell membrane, and it is known that decreased cholesterol levels on IAV virions reduce infectivity. Statins are commonly used to inhibit cholesterol synthesis for preventing cardiovascular diseases, and several studies have investigated whether such inhibition can block IAV infection and propagation, as well as modulate the host immune response to IAV. Taken together, current research suggests that there may be a role for statins in countering IAV infections and modulating the host immune response to prevent or mitigate cytokine storms, and further investigation into this is warranted.
first_indexed 2024-04-12T19:20:52Z
format Article
id doaj.art-bf524eef574e478caf3390c5e2447e02
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T19:20:52Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-bf524eef574e478caf3390c5e2447e022022-12-22T03:19:37ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-09-011310.3389/fimmu.2022.982264982264Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infectionYu-Jyun Li0Yu-Jyun Li1Chi-Yuan Chen2Jeng-How Yang3Ya-Fang Chiu4Ya-Fang Chiu5Ya-Fang Chiu6Ya-Fang Chiu7Department of Microbiology and Immunology, Chang Gung University, Taoyuan, TaiwanGraduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan, TaiwanDepartment of Microbiology and Immunology, Chang Gung University, Taoyuan, TaiwanDivision of Infectious Diseases, Department of Medicine, Chang Gung Memorial Hospital, New Taipei, TaiwanDepartment of Microbiology and Immunology, Chang Gung University, Taoyuan, TaiwanGraduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan, TaiwanResearch Center for Emerging Viral Infections, Chang Gung University, Taoyuan, TaiwanDepartment of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, TaiwanInfluenza A virus (IAV) is widely disseminated across different species and can cause recurrent epidemics and severe pandemics in humans. During infection, IAV attaches to receptors that are predominantly located in cell membrane regions known as lipid rafts, which are highly enriched in cholesterol and sphingolipids. Following IAV entry into the host cell, uncoating, transcription, and replication of the viral genome occur, after which newly synthesized viral proteins and genomes are delivered to lipid rafts for assembly prior to viral budding from the cell. Moreover, during budding, IAV acquires an envelope with embedded cholesterol from the host cell membrane, and it is known that decreased cholesterol levels on IAV virions reduce infectivity. Statins are commonly used to inhibit cholesterol synthesis for preventing cardiovascular diseases, and several studies have investigated whether such inhibition can block IAV infection and propagation, as well as modulate the host immune response to IAV. Taken together, current research suggests that there may be a role for statins in countering IAV infections and modulating the host immune response to prevent or mitigate cytokine storms, and further investigation into this is warranted.https://www.frontiersin.org/articles/10.3389/fimmu.2022.982264/fullinfluenza A virusstatinsinflammatory cytokineslipid raftscholesterol
spellingShingle Yu-Jyun Li
Yu-Jyun Li
Chi-Yuan Chen
Jeng-How Yang
Ya-Fang Chiu
Ya-Fang Chiu
Ya-Fang Chiu
Ya-Fang Chiu
Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection
Frontiers in Immunology
influenza A virus
statins
inflammatory cytokines
lipid rafts
cholesterol
title Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection
title_full Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection
title_fullStr Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection
title_full_unstemmed Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection
title_short Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection
title_sort modulating cholesterol rich lipid rafts to disrupt influenza a virus infection
topic influenza A virus
statins
inflammatory cytokines
lipid rafts
cholesterol
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.982264/full
work_keys_str_mv AT yujyunli modulatingcholesterolrichlipidraftstodisruptinfluenzaavirusinfection
AT yujyunli modulatingcholesterolrichlipidraftstodisruptinfluenzaavirusinfection
AT chiyuanchen modulatingcholesterolrichlipidraftstodisruptinfluenzaavirusinfection
AT jenghowyang modulatingcholesterolrichlipidraftstodisruptinfluenzaavirusinfection
AT yafangchiu modulatingcholesterolrichlipidraftstodisruptinfluenzaavirusinfection
AT yafangchiu modulatingcholesterolrichlipidraftstodisruptinfluenzaavirusinfection
AT yafangchiu modulatingcholesterolrichlipidraftstodisruptinfluenzaavirusinfection
AT yafangchiu modulatingcholesterolrichlipidraftstodisruptinfluenzaavirusinfection